(NASDAQ: WVE) Wave Life Sciences's forecast annual revenue growth rate of 6.29% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 86.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Wave Life Sciences's revenue in 2025 is $93,946,000.On average, 8 Wall Street analysts forecast WVE's revenue for 2025 to be $6,798,798,732, with the lowest WVE revenue forecast at $2,843,840,020, and the highest WVE revenue forecast at $10,036,988,812. On average, 6 Wall Street analysts forecast WVE's revenue for 2026 to be $8,822,906,243, with the lowest WVE revenue forecast at $3,731,843,787, and the highest WVE revenue forecast at $14,688,664,458.
In 2027, WVE is forecast to generate $19,236,421,383 in revenue, with the lowest revenue forecast at $5,251,635,180 and the highest revenue forecast at $45,625,569,882.